Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3687)
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
1,875
Price
$45.32
Total Value
$84.97K
Shares Held After
47,636
% of Holdings
3.8%
Royalty Pharma plc (RPRX)
Coyne Terrance P. — EVP & CFO
Shares
32,916
Price
$45.32
Total Value
$1.49M
Shares Held After
131,664
% of Holdings
20.0%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
3,419
Price
$14.14
Total Value
$48.35K
Shares Held After
141,274
% of Holdings
2.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
100,000
Price
$1.47
Total Value
$147.00K
Shares Held After
1,904,186
% of Holdings
5.3%
ImmunityBio, Inc. (IBRX)
Selecky Christobel — Director
Shares
25,000
Price
$10.00
Total Value
$250.00K
Shares Held After
0
% of Holdings
100.0%
KalVista Pharmaceuticals, Inc. (KALV)
Sweeny Nicole — Chief Commercial Officer
Shares
3,975
Price
$15.57
Total Value
$61.88K
Shares Held After
47,003
% of Holdings
7.8%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
10,034
Price
$15.57
Total Value
$156.20K
Shares Held After
442,883
% of Holdings
2.2%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
165,000
Price
$10.25
Total Value
$1.69M
Shares Held After
2,925,821
% of Holdings
5.3%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
5,354
Price
$15.57
Total Value
$83.34K
Shares Held After
138,983
% of Holdings
3.7%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
4,347
Price
$15.57
Total Value
$67.67K
Shares Held After
226,701
% of Holdings
1.9%
Vir Biotechnology, Inc. (VIR)
Sabatini Brent — SVP, Chief Accounting Officer
Shares
1,829
Price
$7.45
Total Value
$13.63K
Shares Held After
71,043
% of Holdings
2.5%
Vir Biotechnology, Inc. (VIR)
De Backer Marianne — Director
Shares
19,039
Price
$7.45
Total Value
$141.89K
Shares Held After
1,035,466
% of Holdings
1.8%
KalVista Pharmaceuticals, Inc. (KALV)
Piekos Brian — Chief Financial Officer
Shares
1,767
Price
$15.57
Total Value
$27.51K
Shares Held After
13,762
% of Holdings
11.4%
Vir Biotechnology, Inc. (VIR)
de Verneuil Vanina — EVP, General Counsel, Corp Sec
Shares
4,445
Price
$7.45
Total Value
$33.13K
Shares Held After
129,799
% of Holdings
3.3%
Vir Biotechnology, Inc. (VIR)
O'Byrne Jason — EVP & Chief Financial Officer
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
164,249
% of Holdings
1.3%
Vir Biotechnology, Inc. (VIR)
Eisner Mark — EVP and Chief Medical Officer
Shares
2,089
Price
$7.45
Total Value
$15.57K
Shares Held After
157,529
% of Holdings
1.3%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
476
Price
$19.06
Total Value
$9.07K
Shares Held After
325,795
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
10,788
Price
$18.39
Total Value
$198.39K
Shares Held After
326,271
% of Holdings
3.2%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
162,291
Price
$0.60
Total Value
$96.92K
Shares Held After
2,211,757
% of Holdings
6.8%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
143,709
Price
$0.60
Total Value
$85.82K
Shares Held After
1,958,509
% of Holdings
6.8%
Monte Rosa Therapeutics, Inc. (GLUE)
Janku Filip — Chief Medical Officer
Shares
9,189
Price
$19.50
Total Value
$179.16K
Shares Held After
65,837
% of Holdings
12.2%
Vanda Pharmaceuticals Inc. (VNDA)
Honore Tage — Director
Shares
30,000
Price
$8.03
Total Value
$240.90K
Shares Held After
93,469
% of Holdings
24.3%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
5,065
Price
$472.13
Total Value
$2.39M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
9,375
Price
$472.13
Total Value
$4.43M
Shares Held After
0
% of Holdings
100.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
587,390
Price
$27.51
Total Value
$16.16M
Shares Held After
13,736,547
% of Holdings
4.1%
Rallybio Corp (RLYB)
Lieber Jonathan I — Chief Financial Officer
Shares
789
Price
$5.06
Total Value
$3.99K
Shares Held After
4,115
% of Holdings
16.1%
ImmunityBio, Inc. (IBRX)
Simon Barry J. — Director
Shares
10,000
Price
$9.25
Total Value
$92.50K
Shares Held After
3,081,604
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Malenka Robert C. — Director
Shares
2,195
Price
$18.03
Total Value
$39.58K
Shares Held After
337,059
% of Holdings
0.6%
OCULAR THERAPEUTIX, INC (OCUL)
Waheed Nadia — Chief Medical Officer
Shares
3,510
Price
$7.74
Total Value
$27.17K
Shares Held After
314,907
% of Holdings
1.1%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
277,769
Price
$0.61
Total Value
$170.80K
Shares Held After
2,374,048
% of Holdings
10.5%
Tenaya Therapeutics, Inc. (TNYA)
COLUMN GROUP III GP, LP — 10% Owner
Shares
245,965
Price
$0.61
Total Value
$151.24K
Shares Held After
2,102,218
% of Holdings
10.5%
OCULAR THERAPEUTIX, INC (OCUL)
LINDSTROM RICHARD L MD — Director
Shares
60,229
Price
$7.66
Total Value
$461.35K
Shares Held After
246,933
% of Holdings
24.4%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
30,789
Price
$35.46
Total Value
$1.09M
Shares Held After
53,500
% of Holdings
36.5%
NewAmsterdam Pharma Co N.V. (NAMS)
Kastelein Johannes Jacob Pieter — Director
Shares
14,692
Price
$35.00
Total Value
$514.22K
Shares Held After
84,289
% of Holdings
14.8%
RIGEL PHARMACEUTICALS INC (RIGL)
MOOS WALTER H — Director
Shares
4,000
Price
$36.36
Total Value
$145.44K
Shares Held After
12,722
% of Holdings
23.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
60,000
Price
$30.10
Total Value
$1.81M
Shares Held After
432,886
% of Holdings
12.2%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
339,151
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
386
Price
$5.71
Total Value
$2.21K
Shares Held After
339,152
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Bishop John E — See Remarks
Shares
2,792
Price
$5.87
Total Value
$16.38K
Shares Held After
339,538
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
247
Price
$5.71
Total Value
$1.41K
Shares Held After
230,533
% of Holdings
0.1%
ARDELYX, INC. (ARDX)
Hohenleitner Susan — Chief Financial Officer
Shares
1,786
Price
$5.87
Total Value
$10.47K
Shares Held After
230,780
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
151,790
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
602
Price
$5.71
Total Value
$3.44K
Shares Held After
151,792
% of Holdings
0.4%
ARDELYX, INC. (ARDX)
Reilly Joseph James — See Remarks
Shares
4,387
Price
$5.87
Total Value
$25.73K
Shares Held After
152,394
% of Holdings
2.8%
ARDELYX, INC. (ARDX)
MOTT DAVID M — Director
Shares
333,333
Price
$5.84
Total Value
$1.95M
Shares Held After
3,302,918
% of Holdings
10.1%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
1,856,986
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
1
Price
$5.70
Total Value
$5.70
Shares Held After
1,856,988
% of Holdings
0.0%
Roivant Sciences Ltd. (ROIV)
Torti Frank — President and Vant Chair
Shares
1,012,610
Price
$27.15
Total Value
$27.49M
Shares Held After
13,736,547
% of Holdings
6.9%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
2
Price
$5.70
Total Value
$11.40
Shares Held After
1,856,989
% of Holdings
0.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
5,576
Price
$5.71
Total Value
$31.86K
Shares Held After
1,856,991
% of Holdings
0.3%
Showing 1851–1900 of 3687 transactions (page 38 of 74)